Intelligence · Clinical Development
Pipeline search results
Programs matching “bevacizumab” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 45 pipeline programs matching "bevacizumab" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Bevacizumab
ONCOLYTICS BIOTECH INC
Ras-mutated Metastatic Colorectal Cancer
1 trial -
Bevacizumab
United Therapeutics Europe Ltd
Metastatic Melanoma
1 trial -
Bevacizumab
United Therapeutics Europe Ltd
Recurrent Glioblastoma
1 trial -
Bevacizumab
BRIGHT MINDS BIOSCIENCES INC.
Breast Cancer
1 trial -
Bevacizumab
BRIGHT MINDS BIOSCIENCES INC.
Colorectal Neoplasms
1 trial -
Bevacizumab
The First People's Hospital of Lianyungang
Malignant Pleural Effusion
1 trial -
Bevacizumab
The First People's Hospital of Lianyungang
Ovarian Cancer
1 trial -
Bevacizumab Biosimilar IBI305
The First People's Hospital of Lianyungang
Post-orthotopic Liver Transplantation
1 trial -
Bevacizumab combined with Oxaliplatin and TAS-102
The First People's Hospital of Lianyungang
Advanced Colorectal Cancer
1 trial -
Bevacizumab/Irinotecan
Solid Biosciences
Glioblastoma
1 trial -
Cohort C: bevacizumab
Edesa Biotech
Acute Respiratory Distress Syndrome (ARDS)
1 trial -
Folfox plus Bevacizumab and reolysin
ONCOLYTICS BIOTECH INC
Colorectal Cancer
1 trial -
Niraparib-Bevacizumab
Takeda
Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor
1 trial -
OLAPARIB, BEVACIZUMAB
The George Institute
Advanced FIGO Stage III‐IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer
1 trial -
SYSUCC-CMY-2022-0416
The First People's Hospital of Lianyungang
Nasopharyngeal Carcinoma
1 trial -
TACE with adebrelimab and bevacizumab
The First People's Hospital of Lianyungang
Adebrelimab
1 trial -
Tas-102(Suyuan) combined with bevacizumab
The First People's Hospital of Lianyungang
Colorectal Cancer
1 trial -
bevacizumab
United Therapeutics Europe Ltd
Colorectal Cancer
1 trial -
bevacizumab [Avastin]
Hoffmann-La Roche
Liver Cancer
1 trial -
Bevacizumab
Arrowhead Pharmaceuticals Ireland Limited
Pterygium
1 trial -
Bevacizumab
The First People's Hospital of Lianyungang
Brain Glioma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.